Crotedumab

Tax included
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes.
MedChemExpress 
HY-P99357

Data sheet

Size
Multiple sizes
Reactivity
GCGR
Application
Metabolism-sugar/lipid metabolism
CAS
1452387-69-7